StockData
Entrada Therapeutics, Inc. logo

Entrada Therapeutics, Inc. (TRDA) income statement

TRDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$5.03+0.07 (+1.41%)

Close on Nov 18, 2026Market cap $195.85MP/E –Yield –

See a number that looks wrong?